Stay updated with breaking news from Defocus Incorporated Multiple Segments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A six-year follow-up clinical study published in 2022 on MiYOSMART, the myopia control spectacle lens co-developed by HOYA Vision Care and The Hong Kong Polytechnic University (PolyU), has shown that the patented Defocus Incorporated Multiple Segment
Shanghai Weixing Optical issued a significant payment to HOYA Vision Care to obtain a limited duration license to Defocus Incorporated
Initial evidence-based findings of three-year study strongly supports MiYOSMART portfolioHOYA Vision Care, committed to developing innovative solutions to address the growing problem of myopia progression in children, extended its research to Europe
/PRNewswire/ -- HOYA Vision Care, committed to developing innovative solutions to address the growing problem of myopia progression in children, extended its...
Myopia, or nearsightedness, is a vision condition where individuals can see objects clearly up close but may appear blurred further away. Currently, global data shows that over 22.9 percent of the world population have myopia with 2.7 percent having high myopia. It is predicted to increase to 49.8 percent, 9.8…